FDA panel review set for distal protection device
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel is scheduled to review on February 5 Medtronic's PMA for its distal protection device for capturing embolic debris during the treatment of diseased saphenous vein grafts.